Dose Ranging Study in Elective Total Hip Replacement Surgery

NCT00338897 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
1090
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi